Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial

医学 血管成形术 狭窄 靶病变 再狭窄 外科 病变 血液透析 动静脉瘘 临床终点 气球 切割气球 瘘管 随机对照试验 支架 放射科 内科学 经皮冠状动脉介入治疗 心肌梗塞
作者
Yanqi Yin,Yaxue Shi,Tianlei Cui,Hua Li,Jianghua Chen,Lihong Zhang,Zhengya Yu,Hong Li,Yan Yan,Kun Wu,Qizhuang Jin
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:78 (1): 19-27.e1 被引量:31
标识
DOI:10.1053/j.ajkd.2020.11.022
摘要

Previous studies have illustrated the potential superiority of drug-coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous fistula (AVF) dysfunction due to stenosis. Our trial evaluated the efficacy and safety of DCBs for preventing fistula restenosis in Chinese hemodialysis patients.Multicenter, prospective, randomized, open-label, blinded end point, controlled trial.A total of 161 hemodialysis patients with fistula dysfunction from 10 centers in China.Participants were randomized 1:1 to treatment with initial dilation followed by DCB angioplasty or conventional high-pressure balloon (HPB) angioplasty.The primary end point was target lesion primary patency defined as the target lesion intervention-free survival in conjunction with an ultrasonography-measured peak systolic velocity ratio (PSVR) ≤2.0 at 6 months. The secondary end points included 1) device, technical, clinical, and procedural success; 2) major adverse events; 3) degree of target lesion stenosis at 6 months; and 4) clinically driven target lesion and target shunt revascularization within 12 months.The percentage with target lesion primary patency as defined by a PSVR ≤2.0 was higher in the DCB group than in the control group (65% vs 37%, respectively; rate difference, 28% [95% CI, 13%-43%]; P <0.001) at 6 months. The target lesion and target shunt intervention-free survival of the DCB group were not superior to those of the control group at 6 months (P = 0.3 and P = 0.2, respectively) but were superior at 12 months (target lesion intervention-free survival: 73% for DCB vs 58% for control [P = 0.04]; target shunt intervention-free survival: 73% for DCB vs 57% for control [P = 0.04]). The average degree of target lesion stenoses at 6 months was not significantly different between the 2 groups (44% ± 16% for DCB vs 49% ± 18% for control; P = 0.09). There were no significant differences in major adverse events or in device, technical, clinical, or procedural success rates between the groups.Small sample size; short follow-up period; procedural differences between the 2 groups such as unequal inflation times and balloon lengths.Compared to conventional HPB angioplasty, DCB treatment achieved superior primary patency defined using PSVR measured at 6 months and superior intervention-free survival of both the target lesion and the target shunt at 12 months without evidence of greater adverse events.Funded by ZhuHai Cardionovum Medical Device Co., Ltd.Registered at ClinicalTrials.gov with study number NCT02962141.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赵焱峥完成签到,获得积分10
刚刚
2秒前
天天快乐应助苏小小采纳,获得10
3秒前
大力的小熊猫完成签到 ,获得积分10
4秒前
4秒前
5秒前
蜂蜜柚子完成签到,获得积分10
5秒前
wtfff完成签到 ,获得积分10
5秒前
Wk_Ye发布了新的文献求助10
6秒前
7秒前
Xtals应助欧皇采纳,获得10
8秒前
8秒前
9秒前
www完成签到,获得积分10
9秒前
冰糖雪梨完成签到 ,获得积分10
9秒前
10秒前
spark317完成签到,获得积分10
10秒前
11秒前
方聪发布了新的文献求助10
12秒前
Asma_2104发布了新的文献求助10
12秒前
跳跃尔琴发布了新的文献求助10
12秒前
gzw发布了新的文献求助20
13秒前
14秒前
susu完成签到 ,获得积分10
15秒前
李健的小迷弟应助小鱼儿采纳,获得10
15秒前
Wk_Ye完成签到,获得积分10
16秒前
桀桀完成签到,获得积分10
17秒前
18秒前
hanhan299发布了新的文献求助10
19秒前
恰饭发布了新的文献求助10
19秒前
科研通AI2S应助鱼头采纳,获得10
19秒前
小二郎应助sdahjjyk采纳,获得10
22秒前
CipherSage应助Asma_2104采纳,获得10
22秒前
无心的若山完成签到,获得积分10
22秒前
Wenpandaen应助热心市民小张采纳,获得10
23秒前
23秒前
淡淡的向梦完成签到,获得积分10
23秒前
情怀应助www采纳,获得10
23秒前
共享精神应助咿咿呀呀采纳,获得10
23秒前
占那个完成签到,获得积分10
23秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3134819
求助须知:如何正确求助?哪些是违规求助? 2785712
关于积分的说明 7773883
捐赠科研通 2441585
什么是DOI,文献DOI怎么找? 1298006
科研通“疑难数据库(出版商)”最低求助积分说明 625075
版权声明 600825